Rapid Delivery for COVID-19 Antigen Detection Kit (CLIA) - COVID-19 Antigen Lateral Flow Assay – Genobio

Product Detail

Product Tags

Feedback (2)

Our company promises all buyers of the first-class products and solutions as well as most satisfying post-sale support. We warmly welcome our regular and new shoppers to join us for COVID-19 IgG IgM antibodies, OXA-23 CRE, Candida IgG Antibody Detection Kit (CLIA), And we are able to enable on the lookout for any products with the customers' needs. Make sure deliver the best Assistance, the most beneficial High-quality, The quickly Delivery.

Rapid Delivery for COVID-19 Antigen Detection Kit (CLIA) - COVID-19 Antigen Lateral Flow Assay – Genobio Detail:

Product Introduction

Virusee® COVID-19 Antigen Lateral Flow Assay is a lateral flow immunoassay intend for the qualitative detection SARS-CoV-2 nucleocapsid protein antigens in nasopharyngeal swab and oropharyngeal swab from individuals who are suspected of COVID-19 by their healthcare provider. Equipped with most consumables needed, it is rapid, accurate, cost-effective and user-friendly.

*Currently under evaluation of WHO Emergency Use Listing (EUL). (Application number EUL 0664-267-00).

Characteristics

Name	COVID-19 Antigen Lateral Flow Assay
Method	Lateral Flow Assay
Sample type	Nasopharyngeal swab, Oropharyngeal swab
Specification	20 tests/kit
Detection time	15 min
Detection objects	COVID-19
Stability	The kit is stable for 1 year at 2-30°C

Antigen diagnostic test

Advantage

More choices, more flexibility
Samples applicable: Nasopharyngeal swab, oropharyngeal swab
For saliva test or single serving test kit – choose SARS-CoV-2 Antigen Rapid Test!
Rapid test, easy and fast
Obtain result within 15 min
Visually reading result, easy to interpret
Minimum manual operation, tools provided within the kit

Convenient and cost-saving
Product can be transported and stored at room temperature, reducing costs
Included in China white list
Currently under evaluation of WHO Emergency Use Listing (EUL). (Application number EUL 0664-267-00)

What is COVID-19?

In March 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic. The virus is known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease it causes is called coronavirus disease 2019 (COVID-19).

Signs and symptoms of coronavirus disease 2019 (COVID-19) may appear 2 to 14 days after exposure. Common signs and symptoms can include: fever, cough, tiredness, or even a loss of taste or smell, breathing difficulty, muscle aches, chills, sore throat, runny nose, headache, chest pain, etc.

The virus that causes COVID-19 spreads easily among people. Data has shown that the COVID-19 virus spreads mainly from person to person among those in close contact (within about 6 feet, or 2 meters). The virus spreads by respiratory droplets released when someone with the virus coughs, sneezes, breathes, sings or talks. These droplets can be inhaled or land in the mouth, nose or eyes of a person nearby.

Globally, there have been over 258,830,000 confirmed cases of COVID-19, including 5,170,000 deaths reported. A rapid and accurate way for COVID-19 diagnosis is crucial for public healthcare and epidemic control.

Test process

COVID-19 Antigen Lateral Flow Assay 1

Order Information

Model	Description	Product code
VAgLFA-01	20 test/kit	CoVAgLFA-01

Product detail pictures:

Related Product Guide:

Our target is always to satisfy our customers by offering golden support, superior value and high quality for Rapid Delivery for COVID-19 Antigen Detection Kit (CLIA) - COVID-19 Antigen Lateral Flow Assay – Genobio , The product will supply to all over the world, such as: Norwegian, Honduras, Pakistan, With the aim of "compete with good quality and develop with creativity" and the service principle of "take customers' demand as orientation", we will earnestly provide qualified products and solutions and good service for domestic and international customers.

antibiotic-resistant bacteria